Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · UFP Technologies (UFPT)

UFP Technologies Q1 net income rises 35% to $17.2 million; sales up 41%

Positive Impact 3 of 5 earnings Written later

UFP Technologies reported first-quarter 2025 results, with net sales of $148.1 million, up 41.1% from $105.0 million a year earlier, and net income of $17.2 million, or $2.21 per diluted share, versus $1.64 in the first quarter of 2024. Organic sales growth was 2.3%, and gross margin edged down to 28.5% from 28.6%. The press release does not include financial guidance.

Key points

  • Net sales rose 41.1% to $148.1 million for the quarter ended March 31, 2025, from $105.0 million; medical market sales rose 50.4% to $135.4 million.
  • Net income rose 35.4% to $17.2 million, and diluted EPS was $2.21 versus $1.64 a year earlier.
  • Organic sales growth was 2.3%, and gross margin was 28.5% versus 28.6% in the first quarter of 2024.
  • Long-term debt, excluding current installments, was $170.3 million at March 31, 2025, down from $176.9 million at December 31, 2024.

The filing

CompanyUFP Technologies (UFPT)
Form8-K, current report
Filed with the SECMay 7, 2025, 8:39 AM ET
Accession number0001171843-25-002859

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.